openPR Logo
Press release

Personalized Medicine Biomarkers Market Detailed In New Research Report 2025 | Roche Diagnostics, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V.

02-05-2025 08:23 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Personalized Medicine Biomarkers Market Detailed In New

Personalized Medicine Biomarkers Market Size and Trends

Global personalized medicine biomarkers market is estimated to be valued at USD 24.70 Bn in 2024 and is expected to reach USD 68.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 15.6% from 2024 to 2031.

The latest study, "Personalized Medicine Biomarkers Market 2025," published by Coherent Market Insights, offers valuable insights into regional and global markets expected to grow from 2025 to 2032. This in-depth research explores evolving market dynamics, value chain analysis, key investment areas, competitive landscape, regional outlook, and major market segments. It also provides a detailed evaluation of market drivers and constraints. Furthermore, the report highlights strategic opportunities, offering essential guidance for industry professionals, policymakers, stakeholders, investors, and newcomers to help them identify growth strategies, assess market potential, and gain a competitive edge in the Personalized Medicine Biomarkers Market.

The primary objective of this report is to provide readers with a comprehensive analysis of the Personalized Medicine Biomarkers Market, helping them formulate effective growth strategies, evaluate the competitive landscape, assess their market position, and make well-informed business decisions. It delivers key projections on market size, production, revenue, consumption, CAGR, gross margin, and pricing, backed by the most reliable primary and secondary research methods. Additionally, the report includes various research studies covering market dynamics, pricing trends, production and consumption analysis, company profiles, and manufacturing costs.

Get a Sample Copy of the Report @ https://www.coherentmarketinsights.com/insight/request-sample/7566

Market Scope

This report focuses on the detailed segmentation of the Personalized Medicine Biomarkers Market, covering product types, applications, end-user markets, major geographic regions, and key market competitors. It provides expert insights into current market conditions, past performance, production and consumption trends, supply and demand ratios, and revenue forecasts for the forecast period.

The financial standing of key players, including gross profits, sales volumes, revenue, manufacturing costs, and other financial ratios, is thoroughly assessed. Analytical tools such as investment evaluation, SWOT analysis, and Porter's Five Forces analysis are utilized to examine the production and distribution capabilities of market participants.

Additionally, the report includes an in-depth review of major players, highlighting their financial statements, product benchmarking, and SWOT analysis. The competitive landscape section further explores key development strategies, market share, and ranking analysis of these players on a global scale.

Following are the players analyzed in the report:

◘ Roche Diagnostics
◘ Illumina Inc.
◘ Thermo Fisher Scientific Inc.
◘ QIAGEN N.V.
◘ Agilent Technologies Inc.
◘ Bio-Rad Laboratories Inc.
◘ Siemens Healthineers
◘ Abbott Laboratories
◘ Merck KGaA
◘ Genomic Health Inc.
◘ Myriad Genetics Inc.
◘ Foundation Medicine Inc.
◘ Exact Sciences Corporation
◘ Guardant Health Inc.
◘ Luminex Corporation

The report provides a detailed analysis of major players in the Personalized Medicine Biomarkers Market, covering their product portfolios, market shares, financial performance, regional presence, segment revenues, and SWOT analyses. It explores key strategies such as mergers and acquisitions, product innovations, joint ventures, partnerships, and expansions, along with the latest industry updates. Additionally, the report highlights emerging players in the Personalized Medicine Biomarkers Market, offering insights into new market entrants and their potential impact.

Market Segmentation:

By Type: Genetic Biomarkers, Protein Biomarkers, and Metabolite Biomarkers
By Application: Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, and Others
By End User: Hospitals, Diagnostic Laboratories, and Research Institutions

Buy-Now and Up to 25% Discount @ https://www.coherentmarketinsights.com/insight/buy-now/7566

Geographical Landscape of the Personalized Medicine Biomarkers market:

The Personalized Medicine Biomarkers Market report offers detailed insights into the market landscape, which is further categorized into sub-regions and specific countries. This section of the report not only highlights the market share for each country and sub-region but also identifies potential profit opportunities within these areas.

» North America (United States, Canada, and Mexico)
» Europe (Germany, France, UK, Russia, Italy)
» Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
» Latin America (Brazil, Argentina, Colombia)
» Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Key Benefits of This Report for Stakeholders

⏩In-Depth Market Analysis: Gain a comprehensive understanding of current trends, forecasts, and market dynamics in the Personalized Medicine Biomarkers Market from 2025 to 2032 to identify high-growth opportunities.

⏩Strategic Decision-Making: Utilize Porter's Five Forces analysis to assess buyer and supplier influence, enabling informed business strategies and stronger supplier-buyer relationships.

⏩Opportunity Identification: Leverage detailed market segmentation and size analysis to uncover untapped growth opportunities within the Personalized Medicine Biomarkers Market.

⏩Regional Insights: Identify top-performing countries in each region based on their market revenue contributions to optimize regional strategies.

⏩Competitive Landscape Overview: Access an in-depth analysis of leading market players, providing valuable intelligence to navigate the competitive landscape effectively.

Reasons to Purchase This Report:

✅ Competitive Intelligence: Gain in-depth insights into key competitors to refine your sales and marketing strategies.

✅ Identify Emerging Players: Spot new market entrants with promising product portfolios and develop counter-strategies to maintain your competitive advantage.

✅ Targeted Client Acquisition: Identify potential clients and partners within your target market to optimize business expansion efforts.

✅ Strategic Planning: Analyze the priorities of industry leaders to formulate well-informed tactical initiatives.

✅ Mergers & Acquisitions Strategy: Make data-driven decisions on mergers and acquisitions by identifying top-performing manufacturers and market leaders.

✅ Licensing & Partnership Opportunities: Discover potential partners with innovative projects to enhance your in-licensing and out-licensing strategies.

✅ Presentation & Decision Support: Leverage high-quality data and expert analysis to strengthen internal discussions and external presentations.

This report delivers actionable growth insights through a rigorous research methodology, including secondary data analysis, primary industry interviews, and validation using Coherent Market Insights' regional database. Experts have gathered qualitative and quantitative insights from market participants and industry specialists across the value chain to ensure a comprehensive, reliable assessment.

Buy-Now and Up to 25% Discount @ https://www.coherentmarketinsights.com/insight/buy-now/7566

Questions Answered by the Report:

(1) Which are the dominant players of the Personalized Medicine Biomarkers Market?
(2) What will be the size of the Personalized Medicine Biomarkers Market in the coming years?
(3) Which segment will lead the Personalized Medicine Biomarkers Market?
(4) How will the market development trends change in the next five years?
(5) What is the nature of the competitive landscape of the Personalized Medicine Biomarkers Market?
(6) What are the go-to strategies adopted in the Personalized Medicine Biomarkers Market?

Author of this marketing PR:

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.

📌Contact Us:
Mr. Shah
Coherent Market Insights Pvt. Ltd,
📞U.S.: + 12524771362
📞U.K.: +442039578553
📞AUS: +61-2-4786-0457
📞INDIA: +91-848-285-0837
✉ Email: sales@coherentmarketinsights.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Personalized Medicine Biomarkers Market Detailed In New Research Report 2025 | Roche Diagnostics, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V. here

News-ID: 3850582 • Views:

More Releases from Coherent Market Insights

Current Sensor Market Set to Witness Significant Growth by 2025-2032 - Coherent Market Insights
Current Sensor Market Set to Witness Significant Growth by 2025-2032 - Coherent …
The Current Sensor market is estimated to be valued at USD 3.42 Bn in 2025 and is expected to reach USD 6.75 Bn by 2032, growing at a compound annual growth rate CAGR of 10.2% from 2025 to 2032. ➤ Coherent Market Insights has published an in-depth research report titled "Current Sensor Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This study offers a deep dive into the Current
U.S. Bodyguard Service & Security Consulting Market Evolution by 2032 - Disruptive Innovations, Regional Insights, and Growth Opportunities
U.S. Bodyguard Service & Security Consulting Market Evolution by 2032 - Disrupti …
The U.S. Bodyguard Service & Security Consulting market is estimated to be valued at USD 2.57 Bn in 2025 and is expected to reach USD 3.52 Bn by 2032, growing at a compound annual growth rate CAGR of 4.6% from 2025 to 2032. ➤ Coherent Market Insights has published an in-depth research report titled "U.S. Bodyguard Service & Security Consulting Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This
Single Cell Sequencing Market Set for Dynamic Boom as Key Players Illumina, BD Biosciences, Pacific Biosciences, Thermo Fisher Scientific
Single Cell Sequencing Market Set for Dynamic Boom as Key Players Illumina, BD B …
The qualitative latest Research report (2025-2032) on the Single Cell Sequencing Market 2025 - 2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. ➤ Request a Sample
Nuclear Medicine Equipment Market Set for Demonstrate Strong Growth During 2025-2032 with Key Players GE Healthcare, Siemens Healthineers, Philips, and Canon Medical Systems
Nuclear Medicine Equipment Market Set for Demonstrate Strong Growth During 2025- …
The qualitative latest Research report (2025-2032) on the Nuclear Medicine Equipment Market 2025 - 2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. ➤ Request a Sample

All 5 Releases


More Releases for Biomarkers

Biomarkers Market Soars: Safety Biomarkers Lead with 15.9% Projected Growth from …
The global biomarkers market size was valued at US$ 59.1 Billion in 2021 and is expected to expand at a compound annual growth rate CAGR of 15.3% from 2022 to 2032. Safety Biomarkers are expected to be the highest revenue generating biomarker type, with a projected growth of 15.9% from 2022-2032. Biomarkers, or biological indicators, have revolutionized the fields of medicine and healthcare by enabling early disease detection, personalized treatment, and
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi …
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040 This latest report researches the industry structure, sales, revenue,
Cardiac Biomarkers Market - Unveiling Heart Health: Biomarkers Revolutionizing C …
Newark, New Castle, USA: The "Cardiac Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cardiac Biomarkers Market: https://www.growthplusreports.com/report/cardiac-biomarkers-market/8024 This latest report researches the industry structure, sales, revenue,
Global Companion Diagnostic Cancer Biomarkers Market by types (Protein Biomarker …
Global Companion Diagnostic Cancer Biomarkers Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. The report, titled Companion Diagnostic Cancer Biomarkers presents an in-depth study of the Companion Diagnostic Cancer Biomarkers market. Providing a brief history about the market, the report analyses the entire value chain of the market and points out the key drivers and restraints affecting the growth of the market during the forecast period. The report
Global Biomarkers Market Propelled by Growing Usage of Biomarkers in Medical Are …
A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help
Biomarkers Summit
SMi present their 4th annual conference on Biomarkers Summit Monday 31st January & Tuesday 1st February 2011 Crowne Plaza The-City, London, UK Don’t Miss Out - Visit to register your place today http://www.smi-online.co.uk/preclinical-biomarkers.asp Sponsored by Caprotec Cell Signalling Technology GVK Bio Selventa Millipore Quest Diagnostics RBM SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out